A nurse is assessing a patient with suspected Stevens-Johnson syndrome (SJS). Which assessment finding would be most indicative of this condition?

Mucosal involvement with painful erosions is the hallmark of SJS, distinguishing it from other rashes. Other options describe conditions like erythema multiforme (symmetric rash), urticaria (itchy wheals), or herpes zoster (dermatomal lesions).

Clinical Judgment This question assesses the ability to identify the key clinical signs of Stevens-Johnson Syndrome (SJS), a severe drug-induced skin reaction. The key point is that SJS is not a simple skin rash but a systemic illness involving the mucous membranes, requiring you to Notify HCP!. Option 1, "Mucosal involvement with painful erosions in the mouth and conjunctiva," is the Critical Cue for SJS. Painful erosions in the mouth and conjunctiva pose a direct risk to the patient's swallowing, nutritional intake, and vision, and are a warning sign of progression to toxic epidermal necrolysis (TEN). The other options represent different conditions (e.g., venous stasis dermatitis of the lower extremities, urticaria, herpes zoster) and are thus distinguished from SJS. Memory Tip: When remembering SJS, think of the mnemonic: Stevens-Johnson Syndrome = Serious Sloughing of Skin & Slime membranes (mucous membranes). Alternatively, you can emphasize that mucosal involvement is essential with "Mucosal Must Matter." KR vs US: In Korea, anticonvulsants and allopurinol tend to be emphasized more as causative drugs for SJS/TEN, whereas in the US NGN, comprehensive awareness of all potential triggering drugs (sulfonamides, NSAIDs, antibiotics, etc.) and the importance of verifying the medication history are equally stressed. Additionally, in US nursing practice, when assessing mucosal involvement (especially oral), the oral intake amount is quantitatively documented along with the pain score, and the need for an urgent ophthalmology consultation is more actively emphasized.

Clinical Practice Guide When assessing a patient with suspected SJS:
1. Notify HCP! Immediately report to the attending physician and recommend discontinuing all current medications (including prescriptions, over-the-counter drugs, and herbal medicines).
2. Critical Cue: Systematically assess the oral, conjunctival, nasal, and genital mucosa. Check for oral blisters, ulcers, bleeding, and difficulty swallowing.
3. Evaluate the extent of skin detachment. Check for Nikolsky's sign (skin peeling with gentle friction) and estimate the percentage of body surface area (BSA) involvement (SJS: 30%).
4. Closely monitor vital signs, hydration status (skin turgor, mucosa, urine output), and respiratory status (potential airway mucosal involvement). Caution: In SATA (Select All That Apply) questions, there may be distractor options that list only the appearance of the skin rash (target lesions, scales) as signs of SJS without including mucosal involvement. Remember that a diagnosis of SJS is difficult to make without mucosal involvement. Additionally, the timing of onset (1-3 weeks after starting a drug) is an important clue.